-
Product Name
Emibetuzumab (Synonyms: LA-480)
- Documents
-
Description
Anti-HGFR / c-Met Antibody (Emibetuzumab)
-
Tested applications
ELISA
-
Species reactivity
Human HGFR / c-Met
-
Alternative names
LA-480 antibody
-
Isotype
IgG4SP
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-HGFR / c-Met Antibody (emibetuzumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-HGFR / c-Met Antibody (emibetuzumab) is 99.28%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human c MET His at 2 ug/mL can bind Anti-HGFR / c-Met Antibody (emibetuzumab), EC50=0.004797 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"